Immunostaining for PTK6 in pancreatic cancer tissues from 9 patients demonstrated that PTK6 was highly expressed in 4 patients (44%), mildly to moderately expressed in 2 patients (22%), and not expressed at all in 3 patients (33%). This evidence concerns the gene PTK6 and pancreatic neoplasm.